<?xml version="1.0" encoding="UTF-8"?>
<jcr:root xmlns:jcr="http://www.jcp.org/jcr/1.0" xmlns:cq="http://www.day.com/jcr/cq/1.0" xmlns:mix="http://www.jcp.org/jcr/mix/1.0" xmlns:nt="http://www.jcp.org/jcr/nt/1.0" xmlns:sling="http://sling.apache.org/jcr/sling/1.0"
          jcr:primaryType="cq:Page">
  <jcr:content
    cq:template="/apps/wcm-io-samples/sample-app/templates/content/content"
    jcr:primaryType="cq:PageContent"
    jcr:title="Hyper-IgD syndrome"
    sling:resourceType="/apps/wcm-io-samples/sample-app/components/content/page/content">
    <content
      jcr:primaryType="nt:unstructured"
      sling:resourceType="wcm-io/wcm/parsys/components/parsys">
      <contentheadline
        jcr:primaryType="nt:unstructured"
        sling:resourceType="wcm-io-samples/sample-app/components/content/common/contentHeadline"
        headline="Hyper-IgD syndrome" />
      <contentrichtext
        jcr:primaryType="nt:unstructured"
        sling:resourceType="wcm-io-samples/sample-app/components/content/common/contentRichText"
        text="&lt;p&gt;{{Infobox disease
 | Name           = Hyperimmunoglobulinemia D with recurrent fever
 | Image          = Mevalonic-acid-2D-skeletal.png
 | Caption        = [[Mevalonic acid]]
 | DiseasesDB     = 30161
 | ICD10          =
 | ICD9           =
 | ICDO           =
 | OMIM           = 260920
 | MedlinePlus    =
 | eMedicineSubj  =
 | eMedicineTopic =
 | MeshID         =
}}
&amp;apos;&amp;apos;&amp;apos;Hyperimmunoglobulinemia D with recurrent fever&amp;apos;&amp;apos;&amp;apos; (commonly abbreviated as &amp;apos;&amp;apos;&amp;apos;HIDS&amp;apos;&amp;apos;&amp;apos;) is a [[periodic fever syndrome]] originally described in 1984 by the [[internist]] [[Jos van der Meer|Prof. Jos van der Meer]],&amp;lt;ref name=&amp;quot;pmid6144826&amp;quot;&amp;gt;{{cite journal |author=van der Meer JW, Vossen JM, Radl J, &amp;apos;&amp;apos;et al.&amp;apos;&amp;apos; |title=Hyperimmunoglobulinaemia D and periodic fever: a new syndrome |journal=Lancet |volume=1 |issue=8386 |pages=1087–90 |year=1984 |month=May |pmid=6144826 |doi= 10.1016/S0140-6736(84)92505-4|url=}}&amp;lt;/ref&amp;gt; then at [[Leiden University]] [[Leiden University Medical Centre|Medical Centre]]. No more than 300 cases have been described worldwide.

==Features==
HIDS is one of a number of [[periodic fever syndrome]]s. It is characterised by attacks of [[fever]], [[arthralgia]], [[skin disease|skin lesions]] including cyclical mouth ulcers, and [[diarrhea]]. Laboratory features include an [[acute phase response]] (elevated [[C-reactive protein|CRP]] and [[Erythrocyte sedimentation rate|ESR]]) and markedly elevated [[IgD]] (and often [[IgA]]), although cases with normal IgD have been described.&amp;lt;ref name=Drenth&amp;gt;{{cite journal |author=Drenth JP, van der Meer JW |title=Hereditary periodic fever |journal=N. Engl. J. Med. |volume=345 |issue=24 |pages=1748–57 |year=2001 |month=December |pmid=11742050 |doi=10.1056/NEJMra010200}}&amp;lt;/ref&amp;gt;

It has mainly been described in the [[Netherlands]] and [[France]], although the international registry includes a number of cases from other countries.&amp;lt;ref name=Drenth/&amp;gt;

The [[differential diagnosis]] includes [[fever of unknown origin]], [[familial Mediterranean fever]] (FMF) and [[TNF receptor associated periodic syndrome|familial Hibernian fever]] (or TNFα reception associated periodic syndrome/TRAPS).&amp;lt;ref name=Drenth/&amp;gt;

==Cause==
Virtually all patients with the syndrome have mutations in the [[gene]] for [[mevalonate kinase]], which is part of the [[HMG-CoA reductase pathway]], an important cellular [[metabolic pathway]].&amp;lt;ref name=&amp;quot;pmid10369262&amp;quot;&amp;gt;{{cite journal |author=Drenth JP, Cuisset L, Grateau G, &amp;apos;&amp;apos;et al.&amp;apos;&amp;apos; |title=Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group |journal=Nat. Genet. |volume=22 |issue=2 |pages=178–81 |year=1999 |month=June |pmid=10369262 |doi=10.1038/9696 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid10369261&amp;quot;&amp;gt;{{cite journal |author=Houten SM, Kuis W, Duran M, &amp;apos;&amp;apos;et al.&amp;apos;&amp;apos; |title=Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome |journal=Nat. Genet. |volume=22 |issue=2 |pages=175–7 |year=1999 |month=June |pmid=10369261 |doi=10.1038/9691 }}&amp;lt;/ref&amp;gt; Indeed, similar fever attacks (but normal IgD) have been described in patients with [[mevalonic aciduria]] - an [[inborn error of metabolism]] now seen as a severe form of HIDS.&amp;lt;ref name=Drenth/&amp;gt;

==Pathophysiology==
It is not known how mevalonate kinase mutations cause the febrile episodes, although it is presumed that other products of the cholesterol biosynthesis pathyway, the [[prenylation]] chains ([[geranylgeraniol]] and [[farnesol]]) might play a role.&amp;lt;ref name=Drenth/&amp;gt;

==Therapy==
The recurring fevers are highly unpleasant for patients, but so far only the immunosuppressant drugs [[etanercept]]{{Fact|date=March 2009}} (Enbrel) and [[anakinra]]&amp;lt;ref name=&amp;quot;pmid16871408&amp;quot;&amp;gt;{{cite journal |author=Rigante D, Ansuini V, Bertoni B, &amp;apos;&amp;apos;et al.&amp;apos;&amp;apos; |title=Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome |journal=Rheumatol. Int. |volume=27 |issue=1 |pages=97–100 |year=2006 |month=November |pmid=16871408 |doi=10.1007/s00296-006-0164-x }}&amp;lt;/ref&amp;gt; have been shown to be effective. [[Statin]] drugs might decrease the level of mevalonate and are presently being investigated.

==See also==
* [[List of cutaneous conditions]]

==References==
{{reflist|2}}

==External links==
* [http://www.hids.net HIDSNet homepage]

{{Defects of steroid metabolism}}

[[Category:Cholesterol and steroid metabolism disorders]]
[[Category:Rheumatology]]
[[Category:Autoinflammatory syndromes]]&lt;/p&gt;" />
    </content>
  </jcr:content>
</jcr:root>
